SCHEMBL7670706

SCHEMBL7670706

[O]Cc1cc(C(=O)O)ccn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 8/20 0.57
▸ KDM5C P41229 7/20 0.57
▸ KDM4E B2RXH2 5/20 0.57
▸ KDM4A O75164 5/20 0.57
▸ KDM5B Q9UGL1 5/20 0.57
▸ KDM6B O15054 4/20 0.57
▸ KDM2A Q9Y2K7 4/20 0.57
▸ KDM3A Q9Y4C1 4/20 0.57
▸ KDM5A P29375 3/20 0.57
▸ KDM4D Q6B0I6 2/20 0.57
▸ TET3 O43151 1/20 0.57
▸ BBOX1 O75936 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.57
▸ MAPT P10636 1/20 0.57
▸ ASPH Q12797 1/20 0.57
▸ TET2 Q6N021 1/20 0.57
▸ ALKBH5 Q6P6C2 1/20 0.57
▸ KDM7A Q6ZMT4 1/20 0.57
▸ KDM8 Q8N371 1/20 0.57
▸ TET1 Q8NFU7 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2305108 0.84 KDM4C (0.57) KDM4CKDM5CKDM4EKDM4AKDM5B
SCHEMBL845767 0.82 KDM4C (0.55) KDM4CKDM5CKDM4EKDM4AKDM5B
SCHEMBL12252467 0.82 GABRP (0.58) KDM4CKDM5CKDM4EKDM4AKDM5B
SCHEMBL7668183 0.82 CYP1A2 (0.47) KDM4CKDM5CKDM4EKDM4AKDM5B
SCHEMBL31191238 0.82 KDM4C (0.55) KDM4CKDM5CKDM4EKDM4AKDM5B
SCHEMBL30560163 0.82 KDM4C (0.55) KDM4CKDM5CKDM4EKDM4AKDM5B
SCHEMBL1647272 0.82 CYP1A2 (0.61) KDM4CKDM5CKDM4EKDM4AKDM5B
SCHEMBL28331934 0.82 KDM4C (0.55) KDM4CKDM5CKDM4EKDM4AKDM5B
Hydrochloric Acid SCHEMBL1244313 0.81 GABRP (0.56) KDM4CKDM5CKDM4EKDM4AKDM5B
SCHEMBL481039 0.79 KDM4C (0.52) KDM4CKDM5CKDM4EKDM4AKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 — — US disclosed
CN-1284075-A Novel compounds having CGMP-PDE inhibitory effect MOCHIDA PHARM CO LTD (JP) 2001-02-14 — — CN disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 — — EP disclosed
Send feedback